Jesus J Gomar1, Marc L Gordon2, Dwight Dickinson3, Peter B Kingsley4, Aziz M Uluğ5, Lynda Keehlisen6, Sarah Huet6, Justin J Buthorn6, Jeremy Koppel2, Erica Christen6, Concepcion Conejero-Goldberg6, Peter Davies2, Terry E Goldberg7. 1. Litwin-Zucker Research Center, The Feinstein Institute for Medical Research, Manhasset, New York; FIDMAG Hermanas Hospitalarias, Sant Boi de Llobregat, Spain. 2. Litwin-Zucker Research Center, The Feinstein Institute for Medical Research, Manhasset, New York; Hofstra North Shore Long Island Jewish School of Medicine, Hempstead, New York. 3. National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland. 4. Department of Radiology, North Shore University Hospital, Manhasset, New York. 5. Hofstra North Shore Long Island Jewish School of Medicine, Hempstead, New York; Susan and Leonard Feinstein Center for Neurosciences, The Feinstein Institute for Medical Research, Manhasset, New York. 6. Litwin-Zucker Research Center, The Feinstein Institute for Medical Research, Manhasset, New York. 7. Litwin-Zucker Research Center, The Feinstein Institute for Medical Research, Manhasset, New York; Hofstra North Shore Long Island Jewish School of Medicine, Hempstead, New York. Electronic address: tgoldber@nshs.edu.
Abstract
BACKGROUND: Proton magnetic resonance spectroscopy ((1)H-MRS) studies on healthy aging have reported inconsistent findings and have not systematically taken into account the possible modulatory effect of APOE genotype. We aimed to quantify brain metabolite changes in healthy subjects in relation to age and the presence of the APOE E4 genetic risk factor for Alzheimer's disease. Additionally, we examined these measures in relation to cognition. METHODS: We studied a cohort of 112 normal adults between 50 and 86 years old who were genotyped for APOE genetic polymorphism. Measurements of (1)H-MRS metabolites were obtained in the posterior cingulate and precuneus region. Measures of general cognitive functioning, memory, executive function, semantic fluency, and speed of processing were also obtained. RESULTS: General linear model analysis demonstrated that older APOE E4 carriers had significantly higher choline/creatine and myo-inositol/creatine ratios than APOE E3 homozygotes. Structural equation modeling resulted in a model with an excellent goodness of fit and in which the APOE × age interaction and APOE status each had a significant effect on (1)H-MRS metabolites (choline/creatine and myo-inositol/creatine). Furthermore, the APOE × age variable modulation of cognition was mediated by (1)H-MRS metabolites. CONCLUSIONS: In a healthy aging normal population, choline/creatine and myo-inositol/creatine ratios were significantly increased in APOE E4 carriers, suggesting the presence of neuroinflammatory processes and greater membrane turnover in older carriers. Structural equation modeling analysis confirmed these possible neurodegenerative markers and also indicated the mediator role of these metabolites on cognitive performance among older APOE E4 carriers.
BACKGROUND: Proton magnetic resonance spectroscopy ((1)H-MRS) studies on healthy aging have reported inconsistent findings and have not systematically taken into account the possible modulatory effect of APOE genotype. We aimed to quantify brain metabolite changes in healthy subjects in relation to age and the presence of the APOE E4 genetic risk factor for Alzheimer's disease. Additionally, we examined these measures in relation to cognition. METHODS: We studied a cohort of 112 normal adults between 50 and 86 years old who were genotyped for APOE genetic polymorphism. Measurements of (1)H-MRS metabolites were obtained in the posterior cingulate and precuneus region. Measures of general cognitive functioning, memory, executive function, semantic fluency, and speed of processing were also obtained. RESULTS: General linear model analysis demonstrated that older APOE E4 carriers had significantly higher choline/creatine and myo-inositol/creatine ratios than APOE E3 homozygotes. Structural equation modeling resulted in a model with an excellent goodness of fit and in which the APOE × age interaction and APOE status each had a significant effect on (1)H-MRS metabolites (choline/creatine and myo-inositol/creatine). Furthermore, the APOE × age variable modulation of cognition was mediated by (1)H-MRS metabolites. CONCLUSIONS: In a healthy aging normal population, choline/creatine and myo-inositol/creatine ratios were significantly increased in APOE E4 carriers, suggesting the presence of neuroinflammatory processes and greater membrane turnover in older carriers. Structural equation modeling analysis confirmed these possible neurodegenerative markers and also indicated the mediator role of these metabolites on cognitive performance among older APOE E4 carriers.
Authors: Eric M Reiman; Kewei Chen; Gene E Alexander; Richard J Caselli; Daniel Bandy; David Osborne; Ann M Saunders; John Hardy Journal: Proc Natl Acad Sci U S A Date: 2005-06-02 Impact factor: 11.205
Authors: Manja Lehmann; Jonathan D Rohrer; Matthew J Clarkson; Gerard R Ridgway; Rachael I Scahill; Marc Modat; Jason D Warren; Sebastien Ourselin; Josephine Barnes; Martin N Rossor; Nick C Fox Journal: J Alzheimers Dis Date: 2010 Impact factor: 4.472
Authors: Kejal Kantarci; V Lowe; S A Przybelski; M L Senjem; S D Weigand; R J Ivnik; R Roberts; Y E Geda; B F Boeve; D S Knopman; R C Petersen; C R Jack Journal: Neurology Date: 2011-08-24 Impact factor: 9.910
Authors: Lesley Jones; Peter A Holmans; Marian L Hamshere; Denise Harold; Valentina Moskvina; Dobril Ivanov; Andrew Pocklington; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Jaspreet Singh Pahwa; Nicola Jones; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Heike Kölsch; Hendrik van den Bussche; Isabella Heuser; Oliver Peters; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panos Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Eckhard Rüther; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; John Hardy; Michael C O'Donovan; Michael J Owen; Julie Williams Journal: PLoS One Date: 2010-11-15 Impact factor: 3.240
Authors: Ira Driscoll; Juan C Troncoso; Gay Rudow; Jitka Sojkova; Olga Pletnikova; Yun Zhou; Michael A Kraut; Luigi Ferrucci; Chester A Mathis; William E Klunk; Richard J O'Brien; Christos Davatzikos; Dean F Wong; Susan M Resnick Journal: Acta Neuropathol Date: 2012-08-05 Impact factor: 17.088
Authors: Federica Agosta; Keith A Vossel; Bruce L Miller; Raffaella Migliaccio; Stephen J Bonasera; Massimo Filippi; Adam L Boxer; Anna Karydas; Katherine L Possin; Maria Luisa Gorno-Tempini Journal: Proc Natl Acad Sci U S A Date: 2009-01-22 Impact factor: 11.205
Authors: Stefano Marenco; Christian Meyer; Jan Willem van der Veen; Yan Zhang; Ryan Kelly; Jun Shen; Daniel R Weinberger; Dwight Dickinson; Karen F Berman Journal: Neuropsychopharmacology Date: 2018-07-03 Impact factor: 7.853
Authors: L L de Godoy; A Studart-Neto; M Wylezinska-Arridge; M H Tsunemi; N C Moraes; M S Yassuda; A M Coutinho; C A Buchpiguel; R Nitrini; S Bisdas; C da Costa Leite Journal: AJNR Am J Neuroradiol Date: 2021-08-26 Impact factor: 4.966
Authors: Olga Voevodskaya; Pia C Sundgren; Olof Strandberg; Henrik Zetterberg; Lennart Minthon; Kaj Blennow; Lars-Olof Wahlund; Eric Westman; Oskar Hansson Journal: Neurology Date: 2016-04-15 Impact factor: 9.910
Authors: Zuzana Nedelska; Scott A Przybelski; Timothy G Lesnick; Christopher G Schwarz; Val J Lowe; Mary M Machulda; Walter K Kremers; Michelle M Mielke; Rosebud O Roberts; Bradley F Boeve; David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci Journal: Neurology Date: 2017-08-25 Impact factor: 9.910
Authors: Shankar Tumati; Esther M Opmeer; Jan-Bernard C Marsman; Sander Martens; Fransje E Reesink; Peter P De Deyn; André Aleman Journal: Front Aging Neurosci Date: 2018-04-13 Impact factor: 5.750
Authors: Olga Voevodskaya; Konstantinos Poulakis; Pia Sundgren; Danielle van Westen; Sebastian Palmqvist; Lars-Olof Wahlund; Erik Stomrud; Oskar Hansson; Eric Westman Journal: Neurology Date: 2019-01-04 Impact factor: 9.910